IPO Details for Innova Captab: Date, Review, Price, Allotment Info

-

IPO Details for Innova Captab: Date, Review, Price, Allotment Info

Innova Captab IPO Overview:


IPO Date: December 21 to December 26
Funds Raised: Approximately ₹570 crores
Composition: Fresh issue of ₹320 crores and offer for sale up to 5,580,357 equity shares of ₹10 each
Allocation: Retail quota 35%, QIB 50%, HNI 15%

Business Focus:

Innova Captab is a pharmaceutical company manufacturing products across key therapeutic areas. These include cephalosporins, proton pump inhibitors, anticholinergic and heparin NSAIDs, and a diverse range covering cardiovascular, antioxidant, vitamins, and more.

Performance Highlights:


Recorded the third-highest operating revenue among Indian formulation CDMO players in Fiscal 2022.
Achieved the second-highest operating profit margin and net profit margin.
Ranked second for return on capital employed.
Product Portfolio:
The company boasts a diverse generics product portfolio of over 600 products, marketed under its brands in India through a network of 5,000 distributors, stockists, and 150,000 retail pharmacies. Additionally, it exports branded generic products to multiple countries.

R&D and Manufacturing:

Innova Captab operates a dedicated R&D laboratory and pilot equipment in Baddi, Himachal Pradesh, recognized by the DSIR. Plans include establishing a new R&D center in Panchkula, Haryana. Manufacturing takes place in GMP-certified facilities in Baddi, Himachal Pradesh, and a new facility planned in Jammu.

Global Presence:

Exporting to 20 countries in Fiscal 2023, the company has a significant international footprint.

Investors and stakeholders are closely watching Innova Captab's IPO, given its robust financial performance and strategic market presence.

Disclaimer: This article is pure understanding of Gyaanleikh Team and we don't allow you to rely on the same.

Innova Captab IPO
Innova Captab IPO details
IPO December 2023
Pharma IPO India
Pharmaceutical manufacturing
CDMO player
Therapeutic areas in pharmaceuticals
GMP-certified facilities
Pharmaceutical R&D
Export of generic products




Comments

Post a Comment

Best Blogs

IB Interview Questions: M&A : Level 1 M&A Questions

-
Image
1. Why do companies merge? While are many reasons that companies merge the underlying driver of most M&A deals to expedite growth and/or generate cost savings to create value for the owners of the business. When people say that M&A is an ‘art’ and a ‘science’, what does that mean? The science refers to the mechanical valuation methods (Comps, DCF, etc.), but the art is in making a judgment call on valuation based on the outputs of the various valuation methodologies. 2. Who can pay more when buying a company: a Financial buyer or Strategic buyer? Why? Strategic (i.e. corporate) buyers can typically pay more than Financial (i.e. Private Equity) buyers because strategic buyers typically have overlapping operations that can be removed post-merger to generate cost savings (i.e. Synergies). 3. When are sponsors and corporate buyers on equal footing? When a Financial buyer already owns a competing asset, they can generate synergies (which justifies a higher price) and thus are on mor...
Read more

Getting into Investment Banking: A Comprehensive Guide

-
Image
Introduction Breaking into investment banking (IB) is no small feat, whether you're pre-MBA or post-MBA, from a target or non-target school. While high GPAs and test scores are standard, they are often not enough to stand out. Here’s a strategic approach to help you embark on a successful investment banking career. 1. Network Extensively When your application lands at an investment bank, it’s usually reviewed by a small team of bankers responsible for recruiting from specific schools. Given the competitive nature of this field, networking is crucial. Why Networking Matters: Decision-making bankers are more likely to advocate for you if they know you. Especially vital for non-target school students. Engage with alumni and other connections at your target firms. How to Network: Start reaching out to analysts and associates a few months before core recruiting starts. Look for non-target alumni if you're from a non-target school; they often help each other out. Demonstrate Interest...
Read more